| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $551.0M | +10.4% |
| Cost of Revenue | $93.8M | +30.8% |
| Gross Profit | $457.1M | +6.9% |
| R&D Expense | $196.8M | +7.0% |
| SG&A Expense | $89.2M | +7.6% |
| Operating Income | -$117.7M | -0.4% |
| Pre-tax Income | -$83.0M | +4.5% |
| Income Tax | $12.8M | -8.9% |
| Net Income | -$95.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185.6M | -19.6% |
| Short-term Investments | $343.4M | +35.6% |
| Accounts Receivable | $192.8M | +14.0% |
| Current Assets | $878.1M | +14.5% |
| Total Assets | $1.66B | +50.8% |
| Current Liabilities | $709.9M | +131.4% |
| Stockholders' Equity | $455.7M | -6.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $115.2M | +93.9% |
| Capital Expenditures | $6.7M | +31.3% |
| Investing Cash Flow | -$532.3M | -272.0% |
| Financing Cash Flow | $371.9M | +796.4% |
| Free Cash Flow | $108.5M | +99.8% |
| +5.1% |
| EPS (Basic) | -$0.86 | +6.5% |
| EPS (Diluted) | -$0.86 | +6.5% |